# ![@Spruce_Bio Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::964742520621039616.png) @Spruce_Bio Spruce Biosciences

Spruce Biosciences posts on X about $sprb, events, in the, nasdaq the most. They currently have [---] followers and [--] posts still getting attention that total [--] engagements in the last [--] hours.

### Engagements: [--] [#](/creator/twitter::964742520621039616/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::964742520621039616/c:line/m:interactions.svg)

- [--] Week [-----] -15%
- [--] Month [-----] +1,114%
- [--] Months [-----] +323%
- [--] Year [-----] +372%

### Mentions: [--] [#](/creator/twitter::964742520621039616/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::964742520621039616/c:line/m:posts_active.svg)

- [--] Week [--] -7.10%
- [--] Month [--] +367%
- [--] Months [--] +100%
- [--] Year [--] +143%

### Followers: [---] [#](/creator/twitter::964742520621039616/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::964742520621039616/c:line/m:followers.svg)

- [--] Week [---] +1.40%
- [--] Month [---] +6%
- [--] Months [---] +39%
- [--] Year [---] +46%

### CreatorRank: undefined [#](/creator/twitter::964742520621039616/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::964742520621039616/c:line/m:influencer_rank.svg)

### Social Influence

**Social category influence**
[stocks](/list/stocks)  58.62% [finance](/list/finance)  10.34% [exchanges](/list/exchanges)  6.9% [countries](/list/countries)  6.9%

**Social topic influence**
[$sprb](/topic/$sprb) #5, [events](/topic/events) 10.34%, [in the](/topic/in-the) 6.9%, [nasdaq](/topic/nasdaq) 6.9%, [japan](/topic/japan) 6.9%, [$4521t](/topic/$4521t) 6.9%, [acquisition](/topic/acquisition) 3.45%, [longterm](/topic/longterm) 3.45%, [share](/topic/share) 3.45%, [symbol](/topic/symbol) 3.45%

**Top accounts mentioned or mentioned by**
[@yanir_uliel](/creator/undefined) [@caresfoundation](/creator/undefined) [@sprucebiocom](/creator/undefined) [@hcwco](/creator/undefined) [@caresfoundations](/creator/undefined) [@hansgnt05391203](/creator/undefined)

**Top assets mentioned**
[Spruce Biosciences, Inc. (SPRB)](/topic/$sprb)
### Top Social Posts
Top posts by engagements in the last [--] hours

"The FDA has granted Breakthrough Therapy Designation for tralesinidase alfa enzyme replacement therapy (#TA-ERT) for the treatment of #MPSIIIB. Biologics License Application remains on track for Q1 [----]. $SPRB https://investors.sprucebio.com/news-releases/news-release-details/spruce-biosciences-receives-us-fda-breakthrough-therapy https://investors.sprucebio.com/news-releases/news-release-details/spruce-biosciences-receives-us-fda-breakthrough-therapy"  
[X Link](https://x.com/Spruce_Bio/status/1975170632775070119)  2025-10-06T12:05Z [---] followers, [----] engagements


"Today we announced our new corporate strategy & acquisition of tralesinidase alfa enzyme replacement therapy (TA-ERT) for the treatment of #SanfilippoSyndrome Type B (MPS IIIB). Read the full announcement & find todays conference call details: $SPRB https://investors.sprucebio.com/news-releases/news-release-details/spruce-biosciences-announces-new-corporate-strategy-and https://investors.sprucebio.com/news-releases/news-release-details/spruce-biosciences-announces-new-corporate-strategy-and"  
[X Link](https://x.com/anyuser/status/1912099965519675558)  2025-04-15T11:05Z [---] followers, [----] engagements


"Today we announced our first quarter [----] financial results and corporate updates. Visit our News & Events page to learn more about our latest company highlightsand pipelineupdates. https://investors.sprucebio.com/news-releases/news-release-details/spruce-biosciences-reports-first-quarter-2025-financial-results https://investors.sprucebio.com/news-releases/news-release-details/spruce-biosciences-reports-first-quarter-2025-financial-results"  
[X Link](https://x.com/anyuser/status/1919845597193920652)  2025-05-06T20:03Z [---] followers, [---] engagements


"Today we announced that the company has received approval to resume trading on the Nasdaq Capital Market subject to our regaining compliance with Nasdaqs minimum bid price requirement on or before August [--] [----]. Learn more in the press release: $SPRB https://investors.sprucebio.com/news-releases/news-release-details/spruce-biosciences-announces-conditional-nasdaq-approval-resume https://investors.sprucebio.com/news-releases/news-release-details/spruce-biosciences-announces-conditional-nasdaq-approval-resume"  
[X Link](https://x.com/anyuser/status/1933132884493181074)  2025-06-12T12:02Z [---] followers, [---] engagements


"Were pleased to share results from a long-term data integration of tralesinidase alfa enzyme replacement therapy (TA-ERT) clinical program in patients with Sanfilippo Syndrome Type B (MPS IIIB). More on these data & the urgent need for treatment here: https://investors.sprucebio.com/news-releases/news-release-details/spruce-biosciences-announces-integrated-long-term-clinical-data https://investors.sprucebio.com/news-releases/news-release-details/spruce-biosciences-announces-integrated-long-term-clinical-data"  
[X Link](https://x.com/anyuser/status/1956086079695806583)  2025-08-14T20:10Z [---] followers, [---] engagements


"Today we announced our second quarter [----] financial results and corporate updates. Visit our News & Events page to learn more about our latest company highlights and pipeline updates and view the press release here: $SPRB https://investors.sprucebio.com/news-releases/news-release-details/spruce-biosciences-reports-second-quarter-2025-financial-results https://investors.sprucebio.com/news-releases/news-release-details/spruce-biosciences-reports-second-quarter-2025-financial-results"  
[X Link](https://x.com/anyuser/status/1956087529381249525)  2025-08-14T20:16Z [---] followers, [---] engagements


"We announced that the company has resumed trading on the Nasdaq Capital Market at the market open today September [--] with the ticker symbol SPRB and CUSIP 85209E [---]. Learn more in the press release: $SPRB https://investors.sprucebio.com/news-releases/news-release-details/spruce-biosciences-resumes-trading-nasdaq-capital-market https://investors.sprucebio.com/news-releases/news-release-details/spruce-biosciences-resumes-trading-nasdaq-capital-market"  
[X Link](https://x.com/anyuser/status/1967623371723882694)  2025-09-15T16:15Z [---] followers, [---] engagements


"Today we announced our third quarter [----] financial results and corporate updates. Visit our News & Events page to learn more about our latest company highlights including our recent financing and grant of Breakthrough Therapy Designation. $SPRB https://investors.sprucebio.com/news-releases/news-release-details/spruce-biosciences-reports-third-quarter-2025-financial-results https://investors.sprucebio.com/news-releases/news-release-details/spruce-biosciences-reports-third-quarter-2025-financial-results"  
[X Link](https://x.com/anyuser/status/1987991974809661649)  2025-11-10T21:13Z [---] followers, [---] engagements


"We welcome Keli Walbert to our Board of Directors. Keli brings decades of commercial leadership experience and a deep understanding of the rare disease landscape which will be invaluable as we prepare for a transformative year ahead. https://investors.sprucebio.com/news-releases/news-release-details/spruce-biosciences-appoints-proven-pharmaceutical-commercial https://investors.sprucebio.com/news-releases/news-release-details/spruce-biosciences-appoints-proven-pharmaceutical-commercial"  
[X Link](https://x.com/anyuser/status/2000559462281797909)  2025-12-15T13:31Z [---] followers, [---] engagements


"Today we announced we secured up to $50 million in growth capital from Avenue Capital. This strategic financing agreement will support the BLA filing of TA-ERT for the treatment of MPS IIIB while also accelerating pre-launch commercial activities. https://investors.sprucebio.com/news-releases/news-release-details/spruce-biosciences-secures-50-million-growth-capital-avenue https://investors.sprucebio.com/news-releases/news-release-details/spruce-biosciences-secures-50-million-growth-capital-avenue"  
[X Link](https://x.com/anyuser/status/2009249300086473146)  2026-01-08T13:02Z [---] followers, [---] engagements


"Next week we will present two data presentations of our tralesinidase alfa enzyme replacement therapy (TA-ERT) at the 22nd Annual WORLDSymposium. #WORLDSymposia $SPRB https://investors.sprucebio.com/news-releases/news-release-details/spruce-biosciences-announces-data-presentations-22nd-annual https://investors.sprucebio.com/news-releases/news-release-details/spruce-biosciences-announces-data-presentations-22nd-annual"  
[X Link](https://x.com/anyuser/status/2016497406830162013)  2026-01-28T13:03Z [---] followers, [----] engagements


"Weve welcomed two new additions to our leadership team to bolster our regulatory and clinical development expertise Daven Mody Pharm.D. as SVP of Regulatory & Quality and Bruno Gagnon B.Pharm. MSc as SVP Clinical Development Operations. https://investors.sprucebio.com/news-releases/news-release-details/spruce-biosciences-adds-regulatory-and-clinical-development https://investors.sprucebio.com/news-releases/news-release-details/spruce-biosciences-adds-regulatory-and-clinical-development"  
[X Link](https://x.com/anyuser/status/2018671314660442356)  2026-02-03T13:02Z [---] followers, [---] engagements


"Long -Term data presented today at the 22ndAnnual WORLDSymposium highlighted Tralesinidase Alfa Enzyme Replacement Therapys (TA-ERT) as the first disease-modifying treatment option for Sanfilippo Syndrome Type B (MPS IIIB). $SPRB https://investors.sprucebio.com/news-releases/news-release-details/long-term-data-presented-22nd-annual-worldsymposiumtm-highlights https://investors.sprucebio.com/news-releases/news-release-details/long-term-data-presented-22nd-annual-worldsymposiumtm-highlights"  
[X Link](https://x.com/anyuser/status/2019518286501933463)  2026-02-05T21:07Z [---] followers, [----] engagements


"We're excited to announce a strategic partnership with Kaken Pharmaceutical to develop and commercialize #tildacerfont for the treatment of #CAH in Japan: $SPRB https://bit.ly/3IrHWLW https://bit.ly/3IrHWLW"  
[X Link](https://x.com/Spruce_Bio/status/1611108945971802112)  2023-01-05T21:14Z [---] followers, [----] engagements


"Our new #partnership with #Kaken Pharmaceutical accelerates the commercialization and global development of #tildacerfont in Japan to provide #CAH patients with the novel therapies they need. Hear from our leaders on the importance of this exciting collaboration. $SPRB"  
[X Link](https://x.com/Spruce_Bio/status/1620490289818517505)  2023-01-31T18:32Z [---] followers, [---] engagements


"We enjoyed connecting with the #CAH patient community at the recent @caresfoundation Patient Education Conference. We always value these opportunities to speak with patients their families & industry leaders on current research & patient perspectives. Thanks to all who came"  
[X Link](https://x.com/Spruce_Bio/status/1712570245846602195)  2023-10-12T20:45Z [---] followers, [--] engagements


"Were dedicated to improving treatments for people living with rare #endocrine disorders. Currently #tildacerfont is in late-stage #clinicaltrials for adult patients with classic #CAH. Visit to learn about our CAHmelia program & enrollment criteria"  
[X Link](https://x.com/Spruce_Bio/status/1716489346872758279)  2023-10-23T16:18Z [---] followers, [--] engagements


"Our team will be onsite this January in #SanFrancisco for #JPM2024 If youre attending the conference and interested in connecting with our team get in touch with us: investors@sprucebio.com. #JPM24 $SPRB"  
[X Link](https://x.com/anyuser/status/1740417955844825585)  2023-12-28T17:02Z [--] followers, [---] engagements


"Today we provided an update on our clinical programs upcoming anticipated milestones for [----] and strategic goals for advancing #tildacerfont for the treatment of #CAH. Read more in our [----] outlook news release: $SPRB"  
[X Link](https://x.com/Spruce_Bio/status/1742900426805055675)  2024-01-04T13:26Z [---] followers, [--] engagements


"As we commemorate #MLK Day we reflect on Dr. Kings powerful legacy and its resonance with our commitment to #DEI at Spruce. Today we honor his vision as we continue our efforts to foster a workplace that embraces diversity champions equality and fosters inclusion"  
[X Link](https://x.com/Spruce_Bio/status/1746944751017050171)  2024-01-15T17:17Z [---] followers, [--] engagements


"Today we announced our participation in the upcoming @HCWCO 26th Annual Global Investment Conference in #NYC. Learn more and register for the webcast here: $SPRB https://investors.sprucebio.com/news-releases/news-release-details/spruce-biosciences-participate-hc-wainwright-26th-annual-global https://investors.sprucebio.com/news-releases/news-release-details/spruce-biosciences-participate-hc-wainwright-26th-annual-global"  
[X Link](https://x.com/Spruce_Bio/status/1831061089087631627)  2024-09-03T20:05Z [---] followers, [---] engagements


"Recently our Japanese development partner Kaken Pharmaceutical visited our Spruce #SouthSanFrancisco office to meet with our team and discuss recent progress and development for our investigational drug #tildacerfont. It was a pleasure hosting $SPRB"  
[X Link](https://x.com/Spruce_Bio/status/1709634651893924114)  2023-10-04T18:20Z [---] followers, [---] engagements


"Attending the Guggenheim Securities Healthcare Innovation Conference Connect with our CEO Javier Szwarcberg and tune in to our webcast. More details about our participation here: $SPRB https://investors.sprucebio.com/news-releases/news-release-details/spruce-biosciences-participate-guggenheim-securities-healthcare https://investors.sprucebio.com/news-releases/news-release-details/spruce-biosciences-participate-guggenheim-securities-healthcare"  
[X Link](https://x.com/anyuser/status/1850997967106256931)  2024-10-28T20:27Z [---] followers, [---] engagements


"Happy Halloween and Diwali from Spruce Bio Were happy to gather in our San Francisco office today where we celebrated with a friendly costume contest and catered lunch. Thank you to our team for bringing your enthusiasm and good spirits to the table #Halloween #Diwali"  
[X Link](https://x.com/Spruce_Bio/status/1852121629075345858)  2024-10-31T22:53Z [---] followers, [---] engagements


"Meet Dr. Jung Hee Kim a #Changemaker advancing #CAH treatments and improving patient care in complex endocrinology areas through her research and clinical practice. With over [----] citations her work brings hope to families and shapes the future of rare disease management"  
[X Link](https://x.com/Spruce_Bio/status/1854978994312970399)  2024-11-08T20:07Z [---] followers, [---] engagements


"Today we announced our third quarter [----] financial results and corporate updates. See the full #earnings release to learn more about our latest company highlightsand upcoming milestones: $SPRB https://investors.sprucebio.com/news-releases/news-release-details/spruce-biosciences-reports-third-quarter-2024-financial-results https://investors.sprucebio.com/news-releases/news-release-details/spruce-biosciences-reports-third-quarter-2024-financial-results"  
[X Link](https://x.com/anyuser/status/1855959953795690728)  2024-11-11T13:05Z [---] followers, [---] engagements


"To all families medical professionals and loved ones caring for pediatric #CAH patients: thank you. Your compassion resilience and selflessness are the backbone of your childs health journey. This #NationalFamilyCaregiversMonth we celebrate you"  
[X Link](https://x.com/Spruce_Bio/status/1857490553186771136)  2024-11-15T18:27Z [---] followers, [---] engagements


"#ICYMI: CAH Pulse podcast hosts Stephanie & Dina chat with Lydia who shares how her #CAH journey and @CARESFoundation's impact transformed her. Tune in to hear her inspiring story of love milestones & hope Listen here: https://cahpulse.podbean.com/e/lydia-i-had-no-idea-getting-married-and-having-children-was-a-thing/ https://cahpulse.podbean.com/e/lydia-i-had-no-idea-getting-married-and-having-children-was-a-thing/"  
[X Link](https://x.com/Spruce_Bio/status/1860020098343534769)  2024-11-22T17:58Z [---] followers, [---] engagements


"Todaywe announced topline results from our CAHmelia-204 studyin adultclassic congenital adrenal hyperplasia (#CAH)and our CAHptain-205 study in adult and pediatric CAH. Read the full release: #tildacerfont https://bit.ly/3BcPu4h https://bit.ly/3BcPu4h"  
[X Link](https://x.com/anyuser/status/1866596398541705537)  2024-12-10T21:30Z [---] followers, [---] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing